While the top- and bottom-line numbers for Corteva, Inc. (CTVA) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Corteva, Inc. (CTVA) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.32 per share a year ago.
CTVA's crop protection and seed businesses are gaining traction, supported by new technologies, volume growth and disciplined pricing.
Get a deeper insight into the potential performance of Corteva, Inc. (CTVA) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Corteva, Inc. (CTVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AgTech & Food Innovation sharpens focus as Corteva, Beyond Meat and Ingredion Incorporated drive progress in seeds, protein innovation and clean-label ingredients.
BP teams up with Corteva to form Etlas, a 50-50 JV to grow oilseed crops for SAF and renewable diesel, targeting a large-scale low-carbon fuel supply.
Corteva is splitting into two pure-play companies, with the seed segment (SpinCo) offering superior stability and margin profile. I rate CTVA a buy, driven by SpinCo's consistent revenue growth, high operating margins (26%), and robust market position in seeds, especially corn. SpinCo trades at an implied 9.3x EV/EBITDA, below sector and CTVA's historical average, with potential for significant buybacks and dividend increases post-separation.
Corteva, Inc. (CTVA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here is how Corteva, Inc. (CTVA) and J&J Snack Foods (JJSF) have performed compared to their sector so far this year.
Corteva, Inc. ( CTVA ) Q3 2025 Earnings Call November 5, 2025 9:00 AM EST Company Participants Kimberly Booth - Vice President of Investor Relations Charles Magro - CEO & Director David Johnson - Executive VP & CFO Robert King - Executive Vice President of Crop Protection Business Unit Judd O'Connor - Executive Vice President of Seed Business Unit Conference Call Participants Christopher Parkinson - Wolfe Research, LLC Vincent Andrews - Morgan Stanley, Research Division Kevin McCarthy - Vertical Research Partners, LLC Joel Jackson - BMO Capital Markets Equity Research David Begleiter - Deutsche Bank AG, Research Division Joshua Spector - UBS Investment Bank, Research Division Jeffrey Zekauskas - JPMorgan Chase & Co, Research Division Daniel Rizzo - Jefferies LLC, Research Division Patrick Fischer - Goldman Sachs Group, Inc., Research Division Arun Viswanathan - RBC Capital Markets, Research Division Aleksey Yefremov - KeyBanc Capital Markets Inc., Research Division Kristen Owen - Oppenheimer & Co. Inc., Research Division Matthew DeYoe - BofA Securities, Research Division Patrick Cunningham - Citigroup Inc., Research Division Edlain Rodriguez - Mizuho Securities USA LLC, Research Division Benjamin Theurer - Barclays Bank PLC, Research Division Presentation Operator Good morning, ladies and gentlemen, and thank you for standing by. My name is Kelvin and I will be your conference operator today.
While the top- and bottom-line numbers for Corteva, Inc. (CTVA) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.